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ABSTRACT. Cholestasis is a common complication of total
parenteral nutrition (TPN) in infants. A contributing factor to
the hepatic dysfunction may be a contaminant of the TPN
solution, such as aluminum, that accumulates in liver and may
act as a hepatotoxin. To study the hepatic effects of aluminum,
growing piglets were given daily intravenous injections of alu-
minum, 1.5 mg/kg, for 50 days; pair-fed controls were given
heparinized saline. At sacrifice, liver and serum were obtained.
Liver was analyzed for histopathology and for aluminum con-
tent and localization. The hepatocyte lysosomes of the experi-
mental group showed aluminum peaks by x-ray microanalysis,
whereas the control group did not. No differences in ultrastruc-
ture were noted between the two groups when examined by
electron microscopy. Mean serum total bile acid levels (27.8 &plusmn;
15.9 SD vs 6.3 &plusmn; 1.5 &mu;mol/liter, p < 0.05), mean alkaline
phosphatase (309 &plusmn; 108 vs 180 &plusmn; 27 lU/liter, p = NS), and
mean hepatic copper content (24.8 &plusmn; 4.5 vs 14.4 &plusmn; &mu;g/g dry
weight, p < 0.01), were elevated in the aluminum-loaded piglets,
indicating that cholestasis may have been produced. Also, a
small but significant reduction in serum levels of 25 hydroxy-
vitamin D was found in the aluminum-loaded piglets, suggest-
ing that vitamin D hydroxylation may be impaired. Inasmuch
as lysosomal contents are excreted into the bile, aluminum
accumulation in lysosomes may alter lysosomal function and
possibly affect bile flow or content. (Journal of Parenteral and
Enteral Nutrition 11:293-297, 1987)
Cholestasis and progressive liver disease are common
complications of treatment with prolonged total paren-
teral nutrition (TPN), especially in infants and young
children.’-’ The etiology of the hepatic dysfunction is
unclear and may be multifactorial. One possibility is that
a component of TPN solution may act as a hepatotoxin.’ 1
Aluminum has recently been identified as a contami-
nant of TPN solutions.’ It was initially found in the
casein hydrolysate used as the protein source,5 and, sub-
sequently, has been identified in calcium’ and
phosphate6.7 salts, heparin,f’ and albumin.6. It is also
known to be a contaminant of some solutions used in
hemodialysis.9 Its accumulation in bone9-11 and brain12.13
has been linked to disease in those tissues. Infants and
children treated with TPN for several months or years
may accumulate significant quantities of aluminum in
the liver.14 They may also develop rickets responsive only
to large doses of vitamin D .15
This pilot study was designed to determine whether
hepatic aluminum accumulation could contribute to the




Eight piglets (Amo Farms, Ann Arbor, ~4’III. 6 weeks
old, were studied. Piglets were selected because the study
of aluminum bone toxicity in lower animals, such as rats,
has not consistently produced changes closely analogous
to human bone disease.16 The piglets were divided into
experimental and control groups of four each. Starting
weights of the piglets in the experimental group were 9.7
± 2.1 (SD) kg, range 8.2-12.8; starting weights for the
control group were 9.2 ± 1.6 kg, range 8-11.4. Each
underwent left external jugular venous catheterization
following general anesthesia with 1.5 g ketamine, 0.4 mg
atropine, halothane, and nitrous oxide. The Tigon cath-
eter was tunnelled under the skin and brought out onto
the back. Its patency was maintained by twice daily
flushing with 1-2 ml of heparinized saline.
The four experimental animals were given a daily
intravenous bolus injection of 1.5 mg/kg of elemental
aluminum as aluminum chloride (MCB Reagents,
Darmstadt, West Germany) for 50 days. This dose of
aluminum was selected as being large enough to produce
changes in renal function in dogs. 17
Bolus injection was chosen over continuous intrave-
nous infusion of aluminum because both long-term TPN
and hemodialysis treatments are given periodically,
rather than continuously; thus, aluminum administra-
tion as a contaminant of those solutions is periodic. The
four controls were given an equivalent volume of hepa-
rinized saline over the same time period. Both groups of
animals were pair-fed a diet of Purina Pig Growena Chow
T20 during the course of the study.
At the conclusion of the study period. the piglets were
fasted for 12 hr and then were killed by intravenous
administration of a lethal dose of sodium pentobarbital.
Sections from the right lobe of the liver were then
obtained in aluminum-free containers&dquo; for ultrastruc-
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tural examination and aluminum and copper quantifi-
cation ; aliquots of serum were also obtained in plastic
containers for quantitative aluminum, copper, total bile
acids, alkaline phosphatase, and 25(OH) vitamin D
[25(OH)D] determinations.
Tissue Preparation
Tissue submitted for electron microscopy was cut into
1-mm cubes and fixed in a mixture of 2% paraformalde-
hyde and 2.5% glutaraldehyde in casodylate buffer for 1
hr. It was then washed in phosphate buffer (pH 7.3) and
fixed in 1 % osmium tetroxide in the same buffer for 1
hr. Each specimen then was washed several times with
phosphate buffer, dehydrated in graded alcohol, and em-
bedded in Spurr low-viscosity embedding medium. Ultra-
thin sections were cut on a LKB ultratome III, counter-
stained with uranyl acetate and lead citrate, and observed
under a Phillips EM 301 electron microscope at an
acceleration voltage of 80 kV.18
X-ray Microanalysis
Blocks of piglet hepatic tissue 0.3 tcm thick and not
fixed in osmium were mounted on copper grids and
analyzed for the presence of aluminum. Despite the lack
of osmium fixation in these particular samples, it was
determined that organelle resolution was adequate to
proceed with microanalysis.19 All samples were stained
with lead citrate and uranyl acetate.
For microanalysis, a Phillips 420T scanning transmis-
sion electron microscope (STEM) was used in conjunc-
tion with an Edax energy dispersive x-ray spectrometer
controlled by Tracor Northern TN-2000 automation.
Analysis was performed in the STEM mode of operation;
a low background sample holder was employed.
This apparatus is capable of detecting all elements of
atomic number greater than sodium by means of char-
acteristic x-ray emission resulting from electron beam
bombardment of a region defined by the beam, which
can be focused to a diameter as small as 2 nm. The
accelerating voltage used was 80 kV, and the beam cur-
rent intensity was approximately 0.5 nA. All areas of
visualized hepatocytes were scanned by the electron
beam, and characteristic x-ray emission spectra for alu-
minum were recorded, wherever detectable, as peaks on
a computerized tracing.
A Tracor software background fitting and subtraction
program (+CS) was applied to the peaks to enhance
spectral display. Peaks from the aluminum-loaded piglets
and their pair-fed controls were displayed in such a way
as to compare the curves in the pertinent regions.
Biochemical Determinations
Quantitative determinations of aluminum and copper
in liver and serum were carried out by atomic absorption
spectroscopy as previously described.20, 21
Total serum bile acid concentrations were determined
fluorometrically by the Sterognost 3 alpha Flu’ enzy-
matic method (Nyegaard and Co., Diagnostics Division,
Oslo, Norway.22, 23 Serum alkaline phosphatase determi-
nations were carried out by standard autoanalyzer tech-
niques. Serum levels of 25(OH)D were determined by the
competitive protein binding assay. 21
Statistical analyses were carried out using the Wil-
coxon rank-sum test and paired t-test where appropriate.
RESULTS
The final weights of the pair-fed animals were similar:
17.6 ± 2.8 (SD) kg for the experimental group and 17.9
± 2.0 kg for the controls.
Biochemical Analysis
The biochemical effects of aluminum administration
are shown in Table I. Aluminum loading in the experi-
mental group of piglets resulted in hepatic and serum
aluminum levels significantly greater than those for the
control group.
Cholestasis, as manifested by markedly elevated serum
total bile acid levels occurred in three of the four alumi-
num-loaded piglets ( p < 0.05 compared to controls by
TABLE I
Biochemical effects of aluminum administration
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Wilcoxon rank-sum). Mean serum alkaline phosphatase
levels were higher in the aluminum-loaded group, 309 ±
108 ups 180 ± 27 IU/liter, although the difference was not
significant. The mean hepatic copper content was nearly
2-fold greater (p < 0.01), and the mean serum 25(OH)D
levels were lower (p = 0.05) in the aluminum-loaded
piglets, compared to pair-fed controls.
Ultrastructural Analysis
On routine electron microscopic examination, no qual-
itative differences in hepatocyte glycogen deposition,
organelle size, or shape were apparent between the two
groups. Similarly, no differences in bile ductular width,
patency, or number were seen. Neither bile pigment nor
inflammatory changes were detected in either group.
X-Ray Microanalysis
Figure 1 shows x-ray emission peaks from a lysosome
of an aluminum-loaded piglet hepatocyte and, for com-
parison, from a lysosome of a pair-fed control. Peaks for
aluminum and phosphate are prominent in the lysosome
of the hepatocyte from the aluminum-loaded piglet. Sim-
ilar patterns were detected in the hepatocytes of the
other three aluminum-loaded piglets. This suggests that
aluminum may be found in the lysosomes of the hepa-
tocytes in the experimental group. However, not all
lysosomes within a given hepatocyte were shown to con-
tain aluminum; neither was aluminum detected in every
hepatocyte examined. No aluminum peaks were detected
after scanning the entire grid in any of the controls.
DISCUSSION
Our data indicate that growing piglets receiving a
chronic parenteral aluminum load accumulate large
amounts of aluminum in the liver and blood. Since serum
creatinine was not different between experimental and
control groups, decreased renal function cannot explain
the large discrepancy in aluminum content existing be-
tween the two groups. The small quantity of aluminum,
less than 1 ~g/day, administered to controls with the
heparinized saline clearly had no effect on hepatic or
serum aluminum levels. Cholestasis manifested by ele-
vated serum bile acids developed, despite continued en-
teral stimulation of bile flow by means of feeding.
The elevation of serum alkaline phosphatase levels
and hepatic copper2’ in the aluminum-loaded group are
consistent with the observed cholestatic effect. However,
because osteomalacia was also produced in these pig-
lets,26 it is not clear whether the alkaline phosphatase is
primarily from liver or bone. The mechanism of the
elevated serum bile acid levels is unknown. However,
. another trace element, manganese, can initiate choles-
tasis by affecting canalicular membrane structure and
cellular microfilaments. 27
. The failure to detect ultrastructural histopathology
, suggests that the elevation of serum bile acids may
. precede or be independent of the appearance of other
. hepatic pathology, as has been suggested to occur in
. TPN-associated liver disease.28 It has also been shown
, in rabbits29 and rats30 that infusions of glucose and amino
l acid solutions can acutely decrease bile flow without
altering hepatic histology.
FIG. 1. Computerized tracings of element peaks
from lysosomes of aluminum-loaded (broken line) and
control (solid line) piglet hepatocytes. Arrows desig-
nate peaks for A1 and P in the hepatocyte lysosome
of the aluminum-loaded piglet (keV = thousand elec-
tron volts).
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It is unlikely that halothane anesthesia alone produced
the cholestasis, since the control group also received
halothane. Whether the halothane in some way predis-
posed the aluminum-loaded piglets to cholestasis cannot
be determined at present.
Like most reagent grade crystals of this compound, the
aluminum chloride crystals contain some lead; the lead
content of the brand used was 5 ppm. Each piglet received
an average of less than 1 JIg/day, an insignificant quan-
tity in relation to the amount of aluminum given each
day.
A previous report by Galle and Giudicelli31 described
aluminum deposition in the fibrotic liver of a woman
who had died of dialysis encephalopathy. However, the
possibility of underlying chronic hepatic disease, such as
non-A, non-B hepatitis, was not excluded. The same
report describes changes in hepatocyte lysosomal size
and shape in rats given chronic intraperitoneal injections
of large doses of aluminum. However, no controls were
used in the above-mentioned study, and our animals did
not show these changes.
We can confirm the finding of aluminum in the lyso-
somes seen by Galle and Giudicelli,31 as well as by Ver-
bueken et al. 32 The significance of lysosomal aluminum
accumulation is uncertain. However, since lysosomes
may be a major route of biliary lipid excretion; the
presence of aluminum may alter lysosome-to-bile excre-
tion and contribute to an alteration of either bile com-
position or bile flow.~3 Lysosomal aluminum accumula-
tion may also represent a possible excretory route of
aluminum from the liver via the bile ductules. However,
the biliary route of aluminum excretion was shown to be
insignificant in acutely loaded dogs34 as was enterostomal
aluminum excretion in chronically loaded humans with
normal renal function.35 In our study, the bile ducts of
the piglets were not cannulated; thus, the contribution
of this route to aluminum elimination, in the specific
case of the chronically loaded piglet liver, cannot be
determined.
The lower serum levels of 25(OH)D in the aluminum-
loaded piglets were still within the normal range.36 How-
ever, since the half-life of 25(OH)D in the circulation,
2-4 weeks ’31 is long, changes in hepatic vitamin D 25-
hydroxylase activity may not be readily reflected in the
circulating concentration of the sterol. However, the
lower levels of 25(OH)D in the serum of the aluminum-
loaded piglets in consistent with the hypothesis that 25-
hydroxylase activity may be decreased with aluminum
loading. Data demonstrating a decrease in hepatic micro-
somal cytochrome P450 with aluminum loading in rats
are also consistent with this hypothesis,38 as 25-hydrox-
ylation of vitamin D in the liver is a cytochrome P450-
dependent step.
Finally, the quantities of aluminum deposited in the
livers of the experimental group of piglets are at least
twice those found in patients with dialysis
encephalopathy39 and at least 6-fold greater than those
found in chronically loaded infants receiving aluminum-
contaminated TPN solutions.&dquo; Thus, caution must be
applied in extrapolating the results from our study to
clinical situations. Further studies are necessary to de-
termine whether these changes in liver function are still
present when hepatic aluminum content is adjusted to
the level seen in aluminum-loaded patients.
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